LAG3 Binding Peptides
AssigneeLeidos, Inc.
InventorsGabriel M. Gutierrez, Vinayaka Kotraiah, Timothy W. Phares, James Pannucci, Marc Mansour
Life of this patent
Estimating the term…
Abstract
This disclosure provides peptides which bind to LAG3 and can be used to block the interaction of LAG 3 with other molecules such as MHC-II, FGL1, and α-synuclein. These peptides can be used for various therapeutic purposes, such as inhibiting the progression of a hyperproliferative disorder, including cancer, or inhibiting the progression of a synucleinopathy, inhibiting the progression of sepsis, inhibiting the progression of an infectious disease, and enhancing a response to a vaccine.
Claims25
A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 2, 3, 4, 5, 6, and 7.
Dependencies are inferred from the claim text.